Skip to content

BioLife Solutions BLFS Business Sale Proceeds

Business Sale Proceeds at other companies

Azenta logo
AzentaAZTA
$9M
Revvity logo
RevvityRVTY
$158K-31.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$60.1M+245%
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$198M
STERIS logo
STERISSTE
$0-100%
Standex International logo
Standex InternationalSXI
$0

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDivestitureOfBusinesses.

The official record: BioLife Solutions’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's business sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's business sale proceeds?
BioLife Solutions (BLFS) reported business sale proceeds of $5.88M in Q4 2025.
How has BioLife Solutions's business sale proceeds changed year-over-year?
BioLife Solutions's business sale proceeds decreased by 68.0% year-over-year, from $18.36M to $5.88M.
What does business sale proceeds mean?
Cash received from divesting business units or subsidiaries, net of cash in the disposed entity.